Lifeward Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Lifeward Inc. - overview
Established
2001
Location
Marlborough, MA, US
Primary Industry
Medical Devices & Equipment
About
Rewalk Robotics Ltd. specializes in innovative rehabilitation technologies, particularly focusing on helping individuals with spinal cord injuries regain mobility through advanced exoskeleton systems. Founded in 2001 and headquartered in Marlborough, US, Rewalk Robotics Ltd. develops robotic exoskeletons to aid mobility for those with spinal cord injuries.
The company was founded by Amit Goffer, who has a history of entrepreneurship in technology. Rewalk has undergone strategic pivots and focuses on rehabilitation technologies tailored for various medical conditions. The company raised USD 12. 00 mn in its PIPE funding round, resulting in a total of USD 12.
00 mn raised since inception. The most recent deal occurred on September 12, 2014. Rewalk Robotics focuses on healthcare solutions that enhance quality of life through innovative rehabilitation technologies. Their core offerings include the ReWalk Personal Exoskeleton, designed to enable individuals with spinal cord injuries to stand and walk, and the AlterG Anti-Gravity Systems, which help reduce the impact of gravity on rehabilitation exercises.
Additional products include the ReStore Exo-Suit and MYOLYN FES Cycling systems, which target stroke recovery and neurological rehabilitation. These products cater to patients recovering from various conditions, including spinal cord injuries and strokes, and are distributed mainly in North America and Europe, with a growing presence in Asia. In the year 2025, Rewalk Robotics Ltd. reported a revenue of USD 22.
03 mn and an EBITDA of USD -19. 34 mn. The company generates revenue primarily through direct sales of its rehabilitation products to healthcare providers, rehabilitation centers, and medical facilities, employing B2B partnerships to integrate these solutions into treatment protocols. Rewalk Robotics plans to advance its product offerings, with new rehabilitation technologies in development.
The company targets expansion into international markets such as Asia, aiming to establish a presence by 2025. The recent PIPE funding round of USD 12. 00 mn will be utilized to support these product development initiatives and market expansion efforts.
Current Investors
Israel Healthcare Ventures, SCP Vitalife Partners, TechnionSeed
Primary Industry
Medical Devices & Equipment
Sub Industries
Medical Equipment Distributors
Website
www.golifeward.com/
Verticals
Robotics
Company Stage
Mature
Total Amount Raised
Subscriber access only
Lifeward Inc. - timeline of key events

Lifeward Inc. - financials
| Fiscal Year Ended | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 3,746,000 | 5,869,000 | 7,753,000 | 6,545,000 | 4,873,000 | 4,393,000 | 5,966,000 | 5,511,000 | - | - | - |
| % Revenue Growth (YoY) | - | 56.7% | 32.1% | (15.6%) | (25.5%) | (9.9%) | 35.8% | (7.6%) | - | - | - |
| EBITDA (USD) | (24,736,000) | (29,745,000) | (21,350,000) | (18,751,000) | (13,727,000) | (11,719,000) | (12,389,000) | (18,900,000) | - | - | - |
| Operating Income (USD) | (25,174,000) | (30,441,000) | (21,992,000) | (19,214,000) | (14,048,000) | (12,004,000) | (12,655,000) | (19,102,000) | - | - | - |
| Operating Margin | (672.0%) | (518.7%) | (283.7%) | (293.6%) | (288.3%) | (273.3%) | (212.1%) | (346.6%) | - | - | - |
| % EBITDA Margin | (660.3%) | (506.8%) | (275.4%) | (286.5%) | (281.7%) | (266.8%) | (207.7%) | (343.0%) | - | - | - |
| NET Income (USD) | (25,415,000) | (32,503,000) | (24,717,000) | (21,675,000) | (15,551,000) | (12,976,000) | (12,736,000) | (19,569,000) | - | - | - |
| % Net Margin | (678.5%) | (553.8%) | (318.8%) | (331.2%) | (319.1%) | (295.4%) | (213.5%) | (355.1%) | - | - | - |
Lifeward Inc. - employee data


Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.